Loading
Divi's Laboratories Limited Stock: price and insider trades · India
4 insiders bought €149k of shares over the last 90 days, the latest by Joshita Divi, filed 30 Sept 2026.
Cluster: 3 buyers in 30 daysInsider Decl.
273
Thresholds
n/a
Buy Volume
€448,424
13 ops. · all time
Sell Volume
€23M
155 ops. · all time
Who traded when
BuySaleK. Sridevi8 sales
Divi Madhusudana Rao3 sales
Nimmagadda Venkata Anirudh3 sales
Ch. Venu2 sales
D Radhika2 buys
G.Kelitha2 sales
+12 other insiders
Since the insiders bought
- -0.6%Entry ₹9,249.00 · Close 21 Oct 2026 ₹9,190.00
- -0.6%Entry ₹9,249.00 · Close 21 Oct 2026 ₹9,190.00
- -0.6%Entry ₹9,249.00 · Close 21 Oct 2026 ₹9,190.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Divi's Laboratories Limited Hold (neutral), based on 29 analysts. Average price target: ₹8,571.31.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,036 of 26,280 companies
63.2
score / 100
Value39
Quality87
FCF yld0.1%
Earn yld1.1%
EV/EBITDA·
ROE16%
Gross mgn59%
Net mgn25%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹9,086.00
Analyst consensus
29 analystsHold
₹6,336.00Target ₹8,571.31(-6%)₹11,700.00
Income statement
Revenue₹104.8B
Gross profit₹62B59% margin
EBITDA₹38.7B37% margin
Net income₹25.7B26.0% margin
Valuation
PER (trailing)82.4x
PER (forward)60.1x
P/Book14.4x
Beta0.23
Balance sheet & cash
Market cap₹2.4T
Total debt₹70M
Free Cash Flow₹2.2B
Debt / Equity0%
Profitability & ownership
ROE16.2%
ROA10.1%
% insiders52.0%
% institutions29.3%
Last declaration on 30 September 2026
Declarations273 total
1,005 shares@ ₹9,565.30100.0% of flowEquityMarket PurchaseSEBI:a4b14c5a9b02a33214e8e6fa82fe91bb0e78529a
Canonical exit: 29 Dec 2026 (T+90)
3,500 shares@ ₹9,500.0020.2% of flowEquityPledge CreationSEBI:8392afb28f4a69cc8478b74e39eb346d6f6e5223
300 shares@ ₹9,323.5051.6% of flowEquityMarket PurchaseSEBI:766ffd4d94b89f08e6810131c4f0959bf842e1cc
Canonical exit: 29 Dec 2026 (T+90)
162 shares@ ₹9,428.00100.0% of flowEquityMarket PurchaseSEBI:734fdf8a1ee6a7de80e0e65358ea32ab87b6515b
Canonical exit: 29 Dec 2026 (T+90)
734 shares@ ₹9,438.500.0003% mcap8.4% of flowEquityNoneSEBI:a57944d9d31912ece283b184dba19ca80b09caca
2,000 shares@ ₹9,322.000.0008% mcap22.5% of flowEquityNoneSEBI:2cfdc6c82c0ea7d897adfd88aee7fae58efc2f5a
6,234 shares@ ₹9,363.800.0023% mcap69.2% of flowEquityMarket SaleSEBI:595dde38d33a9718a228d792ec833331f8263544
200 shares@ ₹9,492.500.0001% mcap1.8% of flowEquityMarket SaleSEBI:383e950c568fe39dba424e8b7eff3df82c080d7a
200 shares@ ₹9,280.0020.5% of flowEquityMarket SaleSEBI:f5d70951f7395ddf9224eadac7e83fdb1bacbb02
200 shares@ ₹9,250.0020.4% of flowEquityMarket SaleSEBI:eb0f9c488093004fcca6d42dcd5fc534a43bfda0
200 shares@ ₹8,850.0019.4% of flowEquityMarket SaleSEBI:deade9f9130ab8e457bcb7d8f9257413cb322a02
1,575 shares@ ₹8,560.00100.0% of flowEquityGiftSEBI:c4ee68599ba315df6d3ba5d8b7f752549272fdaa
20,000 shares@ ₹8,416.10100.0% of flowEquityMarket SaleSEBI:505d1b74d7d0ecf6ba76f620ae270fe0c24d355e
200 shares@ ₹8,475.0018.8% of flowEquityMarket SaleSEBI:73f3ee22480bc2628fa3bcefc1d5047f36519308
351 shares@ ₹6,698.60100.0% of flowEquityMarket PurchaseSEBI:568ed03ab7b5945e4c5aa634092e2911e95b617a
Canonical exit: 8 Nov 2026 (T+90)
351 shares@ ₹6,698.60100.0% of flowEquity SharesMarket PurchaseSEBI:799d1ed08a310aa71ea1f3857cb5df36f838e164
Canonical exit: 29 Sept 2026 (T+90)
4,200 shares@ ₹6,550.0021.1% of flowEquityMarket SaleSEBI:457626144e2d7dd9083c589fd4e0974cf8f634d3
300 shares@ ₹6,743.00100.0% of flowEquity SharesGiftSEBI:62d5b893423812ce36b738a3607ff0190ca92784
300 shares@ ₹6,743.00100.0% of flowEquity SharesGiftSEBI:1353f5701ad825736fc7696269b3ca2d5011a3ea
15,800 shares@ ₹6,687.3078.9% of flowEquity SharesMarket SaleSEBI:d9a9175d87be3fdde9abf3fd82a965ccad2f2d61
400 shares@ ₹6,681.90100.0% of flowEquity SharesMarket PurchaseSEBI:e3577b9ced953696ee39ae7afda03bc7a8f307f4
Canonical exit: 1 Sept 2026 (T+90)
1,000 shares@ ₹6,753.00100.0% of flowEquity SharesGiftSEBI:a88bc60229002824d6575b97c8130e9f8485ec37
1,000 shares@ ₹6,753.00100.0% of flowEquity SharesGiftSEBI:4291e674bfaaeb039d525425ed2059af75dc1320
500 shares@ ₹6,413.0017.1% of flowEquity SharesSEBI:1484471dfca64124328313a7cfa6db6c18183c92
500 shares@ ₹6,423.1547.8% of flowEquity SharesSEBI:5f5f42c4247d52320054ad8db6a8bba941167507
25 of 273 declarations
About Divi's Laboratories Limited
Divi's Laboratories Limited, an Indian healthcare and pharma company listed in Bombay, is worth INR 2.4 trillion and remains 52% held by insiders. The record counts 102 filers and 273 filings, including 155 sales worth EUR 23.3 million (median EUR 32,598) and 13 purchases worth EUR 448,424 (median EUR 24,036), or 8% of open-market trades.
The heaviest sales carry the name of Divi Madhusudana Rao: EUR 2,640,573 on May 28, 2024, then EUR 1,531,056 on August 13, 2026 (Promoter Group). Nimmagadda Venkata Anirudh follows with EUR 1,524,779 on March 19, 2025, and K. Sridevi has 20 filings, 19 of them sales. On the buying side, L. Lakshmi bought EUR 98,592 on November 12, 2024; on September 30, 2026, 3 filers bought on the same day for EUR 127,849, including Joshita Divi (Designated Person) for EUR 88,182.
Read moreShow less
The year 2023 holds 70 filings, against 17 in 2025. The first publication dates from June 3, 2021 and the latest from September 30, 2026, with a median delay of 1 day. Over twelve months: 28 filings, 6 purchases and 10 sales.
